Newborn Screening for Pompe Disease: Pennsylvania Experience
Pennsylvania started newborn screening for Pompe disease in February 2016. Between February 2016 and December 2019, 531,139 newborns were screened. Alpha-Glucosidase (GAA) enzyme activity is measured by flow-injection tandem mass spectrometry (FIA/MS/MS) and full sequencing of the GAA gene is perfor...
Sparad:
| Huvudupphov: | , , , , , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
MDPI AG
2020-11-01
|
| Serie: | International Journal of Neonatal Screening |
| Ämnen: | |
| Länkar: | https://www.mdpi.com/2409-515X/6/4/89 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|
